Osteoporosis International

, Volume 14, Issue 5, pp 429–436

The hospital cost of vertebral fractures in the EU: estimates using national datasets

Original Article


The purpose of this study was to estimate the hospital cost of vertebral fractures in the EU using national datasets to explore some of the methodologic limitations associated with such an approach. Hospital costs for vertebral fractures across the EU were compared with the hospital costs associated with hip fractures. Additionally, these costs were placed into the health care context by making comparisons with national health care expenditure. All EU Ministries of Health were contacted to identify national datasets to estimate the average length of stay, cost per diem and the number of patients discharged with vertebral fractures. Where national information was not available expert opinion and data from the relevant literature were used instead. Countries show a marked difference in the length of stay between men and women, with differences ranging from 0.32 days in Austria to 20.2 days in Spain. The average hospitalization rate was found to be 8% across the EU, with higher rates found for men than for women. Interestingly a positive correlation between health expenditure per capita and hospitalization rates was found. The total cost of vertebral fractures in the EU was estimated at €377 million per year. Across the EU the hospital cost of a vertebral fracture was on average 63% that of a hip fracture. National datasets allow us to estimate the cost of vertebral fractures in the EU but show limitations. In the absence of largescale prospective studies, national datasets need to be further refined to ensure more accurate estimations of the cost of vertebral fractures in the EU.


Hospital treatment costs Osteoporosis Vertebral fractures 


  1. 1.
    Nevitt MC, et al (1998) The association of radiographically detected vertebral fracture with back pain and function: a prospective study. Ann Intern Med 128: 793–800Google Scholar
  2. 2.
    Genant HK, et al (1999) Interim report and recommendations of the World Health Organization Task-force for Osteoporosis. Osteoporos Int 10: 259–264Google Scholar
  3. 3.
    Cauley JA, et al (2000) Risk of mortality after clinical fractures. Osteoporos Int 11: 556–561Google Scholar
  4. 4.
    Ross PD, Genant HK, Davis JW (1993) Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int 3: 120–126Google Scholar
  5. 5.
    Ismail AA (2001) Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int 12: 85–90Google Scholar
  6. 6.
    Black DM, et al (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14: 821–828Google Scholar
  7. 7.
    Lindsay R, et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285: 320–323Google Scholar
  8. 8.
    Gold DT (1996) The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone 18[3 Suppl]: S185–S189Google Scholar
  9. 9.
    Johnell O, Gullberg B, Kanis JA (1997) The hospital burden of vertebral fractures in Europe: a study of national register sources. Osteoporos Int 7: 138–144Google Scholar
  10. 10.
    Cooper C, O'Neill T, Silman A, on behalf of the European Vertebral Osteoporosis Study Group (1993) The epidemiology of vertebral fractures. Osteoporos Int 14: 589–597Google Scholar
  11. 11.
    Kanis J, McCloskey E (1992) Epidemiology of vertebral osteoporosis. Bone 13: S1–S10Google Scholar
  12. 12.
    Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8: 611–617Google Scholar
  13. 13.
    Anon (1998) Summary report on osteoporosis in the European Community - Action for prevention. European Communities/European Foundation for Osteoporosis (EFFO; now IOF)Google Scholar
  14. 14.
    Delmas D, Fraser M (1998) European Union challenges member states to fight the "silent epidemic" of osteoporosis. Eurohealth 4: 1–4Google Scholar
  15. 15.
    Johnell O, et al (1992) The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int 4: 253–263Google Scholar
  16. 16.
    Felsenberg D, et al (1998) Prevalence of vertebral deformities in females and males in Germany. Med Klin 93 [Suppl 2]: 31–34Google Scholar
  17. 17.
    The European Prospective Osteoporosis Study (EPOS) Group (2002) Incidence of vertebral fracture in Europe: results from the European Prospective Study (EPOS). J Bone Miner Res: 4: 716–724Google Scholar
  18. 18.
    DeLaet CE, et al (1999) Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study. Osteoporos Int 0: 66–72Google Scholar
  19. 19.
    The European Institute of Women's Health, http://www.eu.int/comm/ employment_social/equ_opp/news/health_en.htm, accessed on September 24, 2001Google Scholar
  20. 20.
    The European Institute of Women's Health, http://www.eurohealth.ie/gender/section7.htm, accessed on September 24, 2001Google Scholar
  21. 21.
    Finnern HW, Sykes DP (2001) The hospital cost of vertebral fractures in the European Union (EU). Osteoporos Int 13 [Suppl 1]: S34Google Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  1. 1.Eli Lilly and Company Limited, Lilly Research CentreWindleshamUK

Personalised recommendations